Chelmsford, MA, United States of America

Andrew Hague

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Enanta Pharmaceuticals, Inc., Infinity Pharmaceuticals, Inc.. Active years: 2016-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Hague. Retrieved from https://idiyas.com/inventor/andrew-hague

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew Hague

Introduction

Andrew Hague is a notable inventor based in Chelmsford, MA (US). He has made significant contributions to the field of chemistry, particularly in the development of processes for synthesizing biologically active molecules. With a total of three patents to his name, Hague's work has implications for the treatment of viral infections.

Latest Patents

Hague's latest patents focus on processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives. These inventions relate to processes and intermediates that are useful in the preparation of biologically active molecules, especially in the synthesis of Respiratory Syncytial Virus (RSV) inhibitors. His work in this area is crucial for advancing therapeutic options for viral infections.

Career Highlights

Throughout his career, Andrew Hague has worked with prominent companies in the pharmaceutical industry. He has been associated with Enanta Pharmaceuticals, Inc. and Infinity Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to significant advancements in drug development.

Collaborations

Hague has collaborated with several professionals in his field, including Matthew Ronsheim and Daniel G Genov. These collaborations have further enriched his research and development efforts.

Conclusion

Andrew Hague's innovative work in the field of chemistry and his contributions to the development of RSV inhibitors highlight his importance as an inventor. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…